Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

SHANGHAI, Dec. 11, 2023 /PRNewswire/ — Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or…

Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial

SHANGHAI, Dec. 11, 2023 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company…

Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East

SINGAPORE and DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ — Keppel Corporation Limited…

China Literature to Acquire Tencent Animation and Comics

HONG KONG, Dec. 11, 2023 /PRNewswire/ — China Literature Limited ("China Literature"…

HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors

WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ — HanAll Biopharma’s partner NurrOn Pharmaceuticals…

First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging Agent

MELBOURNE, Australia and INDIANAPOLIS, Dec. 11, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX,…

Qudian Inc. Reports Third Quarter 2023 Unaudited Financial Results

XIAMEN, China, Dec. 11, 2023 /PRNewswire/ — Qudian Inc. ("Qudian" or "the…